Last reviewed · How we verify

NCT06640699

The Effects of Neurophysiological Facilitation Techniques After Coronary Artery Bypass Graft Surgery

Not yet recruiting NA Last updated 15 October 2024
What this trial tests

NA trial testing exercise in Cardiac Disease in 36 participants. Not yet recruiting.

Timeline
1 November 2024
Primary endpoint
1 February 2025
1 March 2025

Quick facts

Lead sponsorIstanbul University - Cerrahpasa
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment36
Start date1 November 2024
Primary completion1 February 2025
Estimated completion1 March 2025

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul University - Cerrahpasa

Who can join

Adults 50 to 85, any sex, with Cardiac Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to investigate the effects of neurophysiological facilitation techniques, applied in addition to Phase I cardiac rehabilitation in the early postoperative period after coronary artery bypass graft (CABG) surgery, on left ventricular function, respiratory functions, and functional capacity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of exercise

Trials testing the same drug.

Other recruiting trials for Cardiac Disease

Currently open trials in the same condition.

Other Istanbul University - Cerrahpasa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06640699.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing